Shah Capital Management Buys 300,000 Shares of Vitamin Shoppe Inc (VSI) Stock

Vitamin Shoppe Inc (NYSE:VSI) major shareholder Shah Capital Management acquired 300,000 shares of the business’s stock in a transaction dated Monday, February 5th. The shares were bought at an average cost of $3.83 per share, for a total transaction of $1,149,000.00. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Large shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Shah Capital Management also recently made the following trade(s):

  • On Thursday, February 1st, Shah Capital Management bought 5,800 shares of Vitamin Shoppe stock. The stock was acquired at an average cost of $4.11 per share, for a total transaction of $23,838.00.

Shares of Vitamin Shoppe Inc (VSI) traded up $0.17 on Tuesday, hitting $3.87. 323,481 shares of the stock traded hands, compared to its average volume of 780,707. Vitamin Shoppe Inc has a twelve month low of $2.95 and a twelve month high of $23.25. The firm has a market capitalization of $88.72, a P/E ratio of -0.35 and a beta of 0.59. The company has a quick ratio of 0.32, a current ratio of 2.07 and a debt-to-equity ratio of 0.59.

Vitamin Shoppe (NYSE:VSI) last announced its earnings results on Wednesday, November 8th. The specialty retailer reported ($0.03) earnings per share for the quarter, missing the consensus estimate of $0.17 by ($0.20). Vitamin Shoppe had a positive return on equity of 6.17% and a negative net margin of 20.27%. The business had revenue of $288.20 million for the quarter, compared to analyst estimates of $297.61 million. During the same quarter last year, the company posted $0.50 EPS. Vitamin Shoppe’s quarterly revenue was down 8.5% on a year-over-year basis. sell-side analysts forecast that Vitamin Shoppe Inc will post 0.34 earnings per share for the current fiscal year.

Institutional investors and hedge funds have recently made changes to their positions in the company. Macquarie Group Ltd. acquired a new stake in shares of Vitamin Shoppe during the third quarter worth about $101,000. Crossmark Global Holdings Inc. boosted its stake in shares of Vitamin Shoppe by 122.8% during the fourth quarter. Crossmark Global Holdings Inc. now owns 31,320 shares of the specialty retailer’s stock worth $138,000 after buying an additional 17,260 shares during the period. UBS Asset Management Americas Inc. boosted its stake in shares of Vitamin Shoppe by 17,041.4% during the second quarter. UBS Asset Management Americas Inc. now owns 11,999 shares of the specialty retailer’s stock worth $140,000 after buying an additional 11,929 shares during the period. Dynamic Technology Lab Private Ltd boosted its stake in shares of Vitamin Shoppe by 72.7% during the second quarter. Dynamic Technology Lab Private Ltd now owns 17,761 shares of the specialty retailer’s stock worth $207,000 after buying an additional 7,478 shares during the period. Finally, Trexquant Investment LP acquired a new stake in shares of Vitamin Shoppe during the third quarter worth about $243,000. Institutional investors and hedge funds own 98.96% of the company’s stock.

Several equities analysts have issued reports on the stock. Zacks Investment Research upgraded shares of Vitamin Shoppe from a “strong sell” rating to a “hold” rating in a research note on Sunday, January 21st. ValuEngine downgraded shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a research note on Sunday, December 31st. Barclays decreased their price objective on shares of Vitamin Shoppe from $6.00 to $3.00 and set an “equal weight” rating for the company in a research note on Thursday, November 9th. Finally, Morgan Stanley decreased their price objective on shares of Vitamin Shoppe from $7.50 to $4.00 and set an “equal weight” rating for the company in a research note on Thursday, November 9th. Three research analysts have rated the stock with a sell rating and six have given a hold rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $5.00.

TRADEMARK VIOLATION WARNING: This report was originally reported by American Banking News and is owned by of American Banking News. If you are accessing this report on another website, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The original version of this report can be viewed at https://www.americanbankingnews.com/2018/02/06/shah-capital-management-buys-300000-shares-of-vitamin-shoppe-inc-vsi-stock.html.

Vitamin Shoppe Company Profile

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Insider Buying and Selling by Quarter for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply